Illingworth Research GroupTM provides a range of patient-focused clinical services to the biopharmaceutical and medical device industries, specialising in mobile nursing services for clinical trials worldwide.
The transaction is the latest in an increasing number of deals in the Healthcare sector, which demonstrates Knights' capability and reputation as a market leader in the Healthcare sector and active legal and professional services business.
John Illingworth, founder and chairman of Illingworth Research Group Limited, commented: “We engaged Knights on recommendation and they absolutely lived up to that recommendation. The Knights team was incredibly responsive irrespective of the time of day. Their knowledge of the pharmaceutical and healthcare sectors helped with the transaction, which, in a complex and transatlantic environment, was evident. Thanks to the whole team, but in particular David Hayes, who led the team, together with Adrian Rogers. A massive thank you to such a smooth, if at times, overwhelming project. You led us with confidence at every step of the way.”
David Hayes, lead advisor for the Knights plc transaction team, commented: “The transaction marks the successful completion of another high quality cross-border deal in the Healthcare sector during the last 12 months. Our latest team success strengthens our reputation as a leading legal and professional services business and displays both our expertise in the Healthcare sector and our ability to advise on high quality cross-border deals. It was a pleasure to advise the sellers and we wish them and the business all the best for the future.”